Immix Biopharma, Inc.
NASDAQ:IMMXBiotechnology
Healthcare
$7.04 +0.99%
+$0.09 today
- Market cap
- $590.04M
- Beta
- 0.10
- P/E (TTM)
- -10.1
- EPS (TTM)
- -$0.91
52W Low $1.94High $11.61
Volume 1.13M
Average 1.07M
Price history
Immix Biopharma, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+75.12%
Period high
$14.47
Period low
$3.97
Latest
$7.04
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| SC 13G | Oct 27, 2026 | Oct 27, 2026 | |
| 8-K | Sep 30, 2026 | Sep 30, 2026 | |
| 424B5 | Sep 29, 2026 | Sep 29, 2026 | |
| 8-K | Sep 29, 2026 | Sep 29, 2026 | |
| FWP | Sep 29, 2026 | Sep 29, 2026 | |
| SC 13G | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 | |
| 10-Q | Aug 7, 2026 | Aug 7, 2026 | |
| 8-K | Jul 20, 2026 | Jul 20, 2026 | |
| SC 13G/A | Jun 5, 2026 | Jun 5, 2026 | |
| 4 | May 29, 2026 | May 29, 2026 | |
| 4 | May 29, 2026 | May 29, 2026 | |
| 4 | May 29, 2026 | May 29, 2026 |
Competitors
Who does Immix Biopharma, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about IMMX's filings, answered from its disclosures.
What is the latest IMMX filing?
The latest filing shown is 10-Q dated Nov 12, 2026.
How many recent filings does IMMX have?
Intrinsic Alpha currently shows 20 recent filings for IMMX.
Continue the stock analysis
Jump to another research area for this company.